http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-304883-B6
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9db8ef605aaac39e0933b4a7cfa37bb8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295 |
| filingDate | 2013-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ae494d237669bff716bb060a7bac097 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ede00353b0742597563e1a3e7d14f38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa9f760241a0cc127e94a37940bb2969 |
| publicationDate | 2014-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-304883-B6 |
| titleOfInvention | Salophen complexes of iron with heterocyclic N-donor ligands, method of their preparation and their use as drugs in antitumor therapy |
| abstract | Complex iron compounds in oxidation stages + II and + III with salophen {2,2´ - ((1E, 1´E) - (1,2-phenylenebis (azanylyliden)) bis (methanylyliden)) diphenolate (2-)} and complementary N-donor heterocyclic ligands and their crystal solvates, represented by structural formulas I and II, wherein X is 1. to X.sub.4.n. represents any combination of n methanylylidene groups and (4-n) azanylylidene groups, wherein n may be 1 to 2, R 1 is n. to R.sub.8.n. represents hydrogen, alkyl, substituted alkyl, alkenyl, aryl, substituted aryl, hydroxy and amino. Methods for preparing such compounds, a pharmacological composition for use in medicine, and a pharmacological composition for use as a medicament for treating cancer. |
| priorityDate | 2013-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.